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Abstract Ferritin is a ubiquitous iron-storage protein that
has 24 subunits. Each subunit of ferritins that exhibit high
Fe(II) oxidation rates has a diiron binding site, the so-
called ferroxidase center (FC). The role of the FC appears
to be essential for the iron-oxidation catalysis of ferritins.
Studies of the iron oxidation by mammalian, bacterial, and
archaeal ferritin have indicated different mechanisms are
operative for Fe(II) oxidation, and for inhibition of the
Fe(II) oxidation by Zn(II). These differences are presum-
ably related to the variations in the amino acid residues of
the FC and/or transport channels. We have used a combi-
nation of UV–vis spectroscopy, ﬂuorescence spectroscopy,
and isothermal titration calorimetry to study the inhibiting
action of Zn(II) ions on the iron-oxidation process by
apoferritin and by ferritin aerobically preloaded with 48
Fe(II) per 24-meric protein, and to study a possible role of
phosphate in initial iron mineralization by Pyrococcus
furiosus ferritin (PfFtn). Although the empty FC can
accommodate two zinc ions, binding of one zinc ion to the
FC sufﬁces to essentially abolish iron-oxidation activity.
Zn(II) no longer binds to the FC nor does it inhibit iron
core formation once the FC is ﬁlled with two Fe(III).
Phosphate and vanadate facilitate iron oxidation only after
formation of a stable FC, whereupon they become an
integral part of the core. These results corroborate our
previous proposal that the FC in PfFtn is a stable prosthetic
group, and they suggest that its formation is essential for
iron-oxidation catalysis by the protein.
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Abbreviations
BFR Heme-containing bacterioferritin from
Escherichia coli
EcFtnA Escherichia coli ferritin A
FC Ferroxidase center
HuHF Human H-chain ferritin
ITC Isothermal titration calorimetry
MOPS 3-(N-Morpholino)propanesulfonic acid
PfFtn Non-heme ferritin from the hyperthermophilic
archaeal anaerobe Pyrococcus furiosus
Introduction
Two forms of ferritin have been found in different organ-
isms: mini-ferritin, or Dps (DNA-binding proteins from
starved cells), and maxi-ferritin. Mini-ferritin protein
appears to occur only in bacteria [1] and archaea [2]. Maxi-
ferritin has been found in many forms of life, such as
bacteria [3], archaea [4], stramenopiles [5], and vertebrates
[6]. Twelve subunits, mini-ferritin, or 24 subunits, maxi-
ferritin, assemble to make a hollow spherical protein
structure. The function of maxi-ferritin is to oxidize and
store iron in a biologically available and nontoxic form [6].
Mini-ferritin can also oxidize and store iron in its cavity
[7], and it has been proposed to function in the protection
of DNA from reactive oxygen species [8].
In vertebrates, usually two subunits, H, ‘‘heavy chain,’’
and L, ‘‘light chain,’’ make up the 24-meric ferritin,
whereas in bacteria and archaea all 24 subunits are
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have been found in bullfrog ferritin [9], with the catalytic
oxidation activity carried by the H and the M subunits.
Each subunit of maxi-ferritins that is involved in the fast
oxidation of iron has a diiron binding site approximately in
the middle of a four a-helix bundle, which is called the
ferroxidase center (FC). In contrast, the FC of mini-ferritin
is located in the interface between two symmetry-related
subunits; the amino acid residues of the two subunits par-
ticipate in forming the FC [10]. It has been proposed that in
mini-ferritins two ferrous ions bind to the FC, and after
oxidation they leave the FC to form a core [10]. At least
three different mechanisms have been proposed for the
function of maxi-ferritins.
Several studies using different techniques, including
rapid mixing methods [11–13] and circular dichroism/
magnetic circular dichroism spectroscopies [14], have
suggested that in mammalian H-chain maxi-ferritin and
bullfrog M-chain ferritin, the FC is a so-called substrate
active site. Fe(II) is oxidized in the FC and an Fe(III)–O–
Fe(III) unit, which is the precursor of the core, is released
to the cavity [15–19]. On the basis of a recent paramag-
netic-NMR study by Turano et al. [20] using bullfrog M-
chain ferritin, it has been proposed that with a transient
FC substrate site, the Fe(III)–O–Fe(III) product leaves the
FC and passes through a channel system in the protein
shell, forming transient clusters of increasing nuclearity,
and only after oxidation of an approximately 150–200
Fe(II) per protein does the core formation process start. In
contrast, recent EPR [21] and kinetic studies [22] have
suggested that the FC of the non-heme ferritin from the
hyperthermophilic archaeal anaerobe Pyrococcus furiosus
(PfFtn) is a stable prosthetic group. We have proposed
that after formation of a stable diiron center, Fe(II) on its
way to the core is oxidized by the Fe(III) in the FC, and
electrons are transferred to another oxidant such as
molecular oxygen [22]. A somewhat different mechanism
has been proposed for the heme-containing bacterioferritin
from Escherichia coli (BFR), in which Fe(II) oxidation is
catalyzed by a preexisting core with electron transfer to
the FC via a speciﬁc mononuclear ‘‘internal iron’’ site
[23]. This latter mechanism has recently been questioned
with the alternative proposal that the FC of bacterioferritin
B from Pseudomonas aeruginosa acts as a substrate center
for oxidation and as a gate for internalization of iron into
the protein [24]. In PfFtn and BFR, the presence of a
stable FC would likely block passage of Fe(III)–O–Fe(III)
units through the protein shell, and therefore the core
formation process must be different from that proposed for
bullfrog M-chain ferritin by Turano et al. [20]. Thus far,
for PfFtn no indication has been obtained for the occur-
rence of small clusters en route to core formation, and we
assume that core formation starts directly after formation
of the FC.
The amino acid residues of site A of the FC are con-
served among all maxi-ferritins (Fig. 1). Differences in the
residues of site B have been observed. For example, in
PfFtn, site B has a glutamate, Glu130, which is absent in
human H-chain ferritin (HuHF), where it is replaced by an
alanine. In bullfrog M-chain ferritin, there is an aspartate,
Asp140, in the position corresponding to Glu130 in PfFtn,
and BFR has a histidine, His130, here. These variations
may be at the origin of different mechanism of iron oxi-
dation by maxi-ferritins.
It has been shown that binding of other metals such as
Zn(II) and Tb(III) inhibits the iron-oxidation activity of
several ferritins [25–27]. X-ray crystal structures and
kinetic studies of iron oxidation have shown that in bac-
terial ferritin Zn(II) primarily binds to the FC and inhibits
the iron-oxidation process [27, 28]. In mammalian ferritin,
Zn(II) binds to the threefold channels and to the FC [29–
32] and also inhibits iron-oxidation activity. Differences in
the residues of the FC and the threefold channel of ferritins
appear to be the reason for the observed differences in
Zn(II) and Tb(III) binding patterns for mammalian ferritin
versus bacterioferritin.
Certain oxoanions, in particular phosphate and vanadate,
increase the rate of iron core formation [33]. Ferritins
isolated from different sources contain phosphate that is
associated with the core in the protein. In bacterial ferritin,
the phosphate-to-iron ratio can be as high as close to unity
[34, 35]. In contrast, a ratio of approximately 0.1 has been
found in mammalian maxi-ferritin [36]. It has been sug-
gested that phosphate has a role in promoting a core surface
redox reaction [37] and that phosphate can increase the in
vitro oxidation rate of iron by maxi-ferritin [38]. The role
of phosphate in iron deposition into maxi-ferritin is not
understood. On the basis of Mo ¨ssbauer spectroscopy it has
been suggested that phosphate may increase the oxidation
rate of ferrous ion by the FC as a substrate active site in
horse spleen ferritin [39]. The ﬁndings of other kinetic
studies contradict these results and have suggested that
phosphate does not affect the initial rate of iron deposition
into horse spleen ferritin [40].
In a previous study [22] we presented evidence to suggest
thattheFCinPfFtnisastable,catalyticallyactiveprosthetic
group. In the present work we provide further support for
this proposal using Zn(II) binding to PfFtn. We study the
binding of Zn(II) to PfFtn and its effect on the initial oxi-
dation rates of apoferritin and of preloaded ferritin, i.e.,
ferritin in which the 24 FCs have been aerobically preloaded
with48Fe(II),inthepresenceandabsenceofphosphate,and
we explore a possible role of phosphate in initial iron min-
eralization, i.e., formation of a core, by PfFtn.
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Chemicals
Zinc sulfate was purchased from Merck, anhydrous
potassium hydrogen phosphate was from J.T. Baker, and
sodium orthovanadate (99.9% metal basis) was from Alfa
Aesar. All other chemicals were reagent grade and were
purchased from Sigma-Aldrich.
Preparation of apoferritin
PfFtn was expressed and puriﬁed as described before [22].
Apoferritin was prepared by the methods of Bauminger
et al. [41] and Dawson et al. [42] under anaerobic condi-
tions using nitrogen of 5.0 purity (i.e., 99.999% N2). The
iron content of apoferritin was measured using the ferene
method [22]. Apoferritin contains less than one iron per 24-
mer. The protein concentration was determined using the
bicinchoninic acid assay (Pierce) with bovine serum albu-
min as a standard.
Kinetics of Fe(II) oxidation
Thesteady-statekineticsofironmineralizationwasfollowed
using a ﬁber-optic spectrophotometer (Avantes). Progress
curves were measured at 315 nm. Spectra were recorded
from approximately 5 s after addition of an anaerobic solu-
tion of ferrous sulfate. Forty-eight irons per ferritin were
added to apoferritin to prepare preloaded samples. Zinc sul-
fate was used to incubate ferritin with Zn(II) for 10 min.
Kinetic measurements were carried out in 100 mM 3-(N-
morpholino)propanesulfonic acid (MOPS) pH 7.0, using
1-ml glass cuvettes with a path length of 1 cm. The speciﬁc
activity (deﬁned as micromoles of Fe
3? formed per minute
per milligram of 24-meric ferritin) was determined from the
initial rate measured at 315 nm using an extinction coefﬁ-
cient of 2.5 mM
-1 cm
-1 [22].Three batchesof proteinwere
used to measure the kinetics of iron oxidation by apoferritin.
Each experiment was performed at least three times with the
same or a different concentration of protein. Rapid stopped-
ﬂow experiments were carried using a Scientiﬁc PQ/SF-53
preparative quench/stopped-ﬂow instrument with an EG&G
PrincetonAppliedResearch1,024-elementphotodiode-array
detector. Measurements were done at 22 C. Apoferritin
mixed with anaerobic water solution was used as a reference
sample. Fe(II) oxidation was followed at 315 nm.
Isothermal titration calorimetry measurements
Isothermal titration calorimetry (ITC) experiments of
Zn(II) binding to PfFtn were done with a VP-ITC
Fig. 1 Structure of the diiron
binding site of a the Pyrococcus
furiosus ferritin (PfFtn) [Protein
Data Bank (PDB) 2JD7] in
comparison with b the diiron
binding site of human H-chain
ferritin (PDB 1FHA), c bullfrog
M-chain ferritin (PDB 1MFR),
and d the diiron binding site of
Escherichia coli bacterioferritin
(PDB 3E1J)
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pared in the same buffer as the protein, 100 mM MOPS pH
7.0. All solutions were degassed prior to use. Measurements
were performed at 25 C. The experimental parameters for
ITC experiments were as follows: reference power
25 lcal s
-1, initial delay 100 or 600 s, and stirring speed
307 rpm. The results were analyzed with Origin 7.0.
Titration of Zn(II) to the buffer, i.e., in the absence of the
protein, was done and the resulting heat of dilution data
were subtracted from those of Zn(II) binding to the protein.
Each titration was performed twice and the standard devi-
ation of the two independent measurements was deter-
mined. The volume of the ﬁrst injection was 2 ll and the
resulting data point was excluded from ﬁts of the integrated
heat. The volume of each subsequent injection was 3 ll.
Calorimetry and tryptophan ﬂuorescence
Fluorescence emission spectra were collected during a
Zn(II) titration to PfFtn using a Cary spectroﬂuorimeter at
25 C. Excitation was done at 295 nm for tryptophan
excitation [43, 44]. Measurements were done using quartz
cuvettes with a path length of 1 cm. The buffer was 50 mM
MOPS pH 7.0. For each titration [four Zn(II) per 24-mer]
aliquots of 2 ll aqueous ZnSO4 solution was added to 3 ml
protein solution. Approximately 5 min after each addition,
the ﬂuorescence spectra were recorded. Longer incubation
with Zn(II) did not change the spectra.
Results
Effect of Zn(II) on the fast and slow kinetics of Fe(II)
oxidation
It has been shown that Zn(II) decreases the iron-oxidation
rate of certain ferritins by binding to the FC [25–31]. To
determine the effect of Zn(II) on PfFtn, apoferritin was
incubated with various zinc-to-ferritin ratios (i.e., 0–100)
for 10 min, and then an aliquot of 48 Fe(II) per ferritin was
added to each sample and progress curves were measured
at 315 nm. The patterns for apoferritin in the absence of
Zn(II) and for apoferritin preincubated with eight and 24
zincs per ferritin are shown in Fig. 2a.
The progress curves show two phases, an initial fast
oxidation process followed by a slower oxidation process.
The set of progress curves was ﬁtted with a double expo-
nential ﬁt model:
AðtÞ¼  M exp
 t
T1

  N exp
 t
T2

þ M0; ð1Þ
where M and N are the pre-exponential amplitude factors
and T1 and T2 are time constants of the ﬁrst and the second
exponential, respectively. Progress curves were ﬁtted with
a global value for T1, whereas M, N, and T2 were allowed to
differ between traces. The speciﬁc activity at time zero was
calculated from the ﬁrst derivative of ﬁts based on Eq. 1.
The speciﬁc activity for each sample is plotted versus the
zinc-to-ferritin ratio in Fig. 2b. It was found that the spe-
ciﬁc activity of the fast oxidation of Fe(II), attributed to the
oxidation of two Fe(II) in the FC, decreases considerably,
i.e., up to approximately sevenfold, for preincubated sam-
ples with zinc-to-ferritin ratios from 0 to 24. A second,
slower reaction is observed for all preincubated samples
with zinc-to-ferritin ratios higher than zero (Fig. 2c). The
initial rate, N/T2, of iron oxidation in the second reaction is
absent for apoferritin; it starts at a maximum for one zinc
per ferritin, and it then continuously decreases with
increasing zinc-to-ferritin ratio up to 24. Incubation of
PfFtn with 100 Zn(II) per ferritin further decreased the
iron-oxidation activity of the FC up to approximately 55-
fold.
To determine the stoichiometry of Zn(II) binding to
PfFtn and to identify possible additional binding sites, ITC
was used. Apoferritin was titrated with zinc as shown in
Fig. 3. Two association constants (i.e., two independent
binding sites) were required to ﬁt the data. The ﬁrst site has
a higher afﬁnity for Zn(II), K1 = (2.4 ± 0.1) 9 10
4 M
-1,
with a stoichiometry of 1.8 ± 0.1 Zn(II) per subunit. This
group of binding sites is presumably the diiron binding site
in each of the 24 subunits. The second set of binding sites,
with a lower afﬁnity, K2 = (6.2 ± 0.3) 9 10
3 M
-1, has a
stoichiometry of 1.3 ± 0.2 and could be binding to the C
site, or acidic residues in the core. The thermodynamic
parameters are given in Table 1. Binding of Zn(II) to site A
or site B of the FC was marginally resolved: a slightly
better ﬁt to the ITC data was obtained with a three
sequential binding site model. The results give two similar
afﬁnities, K1 = (2.5 ± 0.1) 9 10
4 M
-1 and K2 = (2.2 ±
0.1) 9 10
4 M
-1, for binding of Zn(II) to the each site of
the FC and a lower afﬁnity, K3 = (4.0 ± 0.1) 9 10
3 M
-1,
for binding to a third site.
Zn(II) binding as a probe for studying the functioning
of the FC
To further test our previous proposal [22] that ferric ions
are stable in the diiron binding site and do not leave the
center, PfFtn was incubated with 24 Zn(II) and 48 Fe(II)
per protein in two different orders: (1) incubation of apo-
ferritin with Zn(II) for 10 min and then aerobic incubation
of protein with 48 Fe(II) per protein, and (2) aerobic
incubation of apoferritin with 48 Fe(II) per protein for
approximately 1 h and then 24 Zn(II) per protein for 10
min. An apoferritin sample was incubated with 48 Fe(II)
per monomer in the absence of Zn(II) as a control. The
1246 J Biol Inorg Chem (2010) 15:1243–1253
123progress curve of Fe(III) formation was measured at
315 nm and the results are compared in Fig. 4.
The oxidation rate of 48 Fe(II) added per protein to the
sample that was preincubated for 10 min with 24 Zn(II) per
protein shows a considerable decrease compared with that
of the control sample in the absence of any Zn(II). When
apoferritin was incubated with 24 Zn(II) per protein and
then incubated with 48 Fe(II) per protein for a longer time,
an enhancement in oxidation rate was observed. Apofer-
ritin incubated ﬁrst with 48 Fe(II) per 24-mer, and then
incubated with 24 Zn(II) per protein shows a progress
curve similar to that of the control. The minor inhibitory
effect of Zn(II) on the 48 Fe(II) per protein preloaded
sample does not increase as the time of incubation of the
sample with 24 Zn(II) per protein is increased (not shown).
ITC was performed to check the difference between
Zn(II) binding to apoferritin and to preloaded ferritin with
48 Fe(II) per ferritin. A preloaded sample was incubated at
room temperature at least for 3 h and then at 4 C for
2 days and then Zn(II) binding to the preloaded sample was
measured by ITC (Fig. 5).
Comparing Fig. 5 with Fig. 3, one can see that Zn(II)
titration of the iron-preloaded sample [48 Fe(II) per ferritin
aerobically] does not show the binding pattern of Zn(II)
binding to apoferritin. The results were ﬁtted with a model
of two independent binding sites (Table 1). The ﬁrst site,
with higher afﬁnity, K1 = (3.1 ± 1.0) 9 10
4 M
-1, for
Zn(II) has a stoichiometry of less than 0.10 Zn(II) per
subunit and the second site, with lower afﬁnity,
K2 = (3.3 ± 0.5) 9 10
3 M
-1, has a stoichiometry of
1.6 ± 0.4 Zn(II) per subunit. Presumably, the substoi-
chiometric strong binding is due to a minor quantity of
residual free sites in the more than 95% loaded FCs. Thus,
comparing the thermodynamic parameters of Zn(II) bind-
ing to the 48 Fe(II) aerobically preloaded sample with that
of Zn(II) binding to apoferritin suggests that aerobic
addition of 48 Fe(II) per ferritin to apoferritin ﬁlls the
Zn(II) high-afﬁnity binding sites and Zn(II) is not able to
replace iron from these sites. The afﬁnity and thermody-
namic parameters of Zn(II) binding to the second set of
sites of 48-Fe(II)-preloaded PfFtn are comparable to those
for Zn(II) binding to the second set of sites of apo-PfFtn.
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Fig. 2 Effect of Zn(II) on the
initial rate of iron oxidation by
PfFtn. The concentration of
apoferritin was 0.6 lM
and measurements were
done in 100 mM 3-(N-
morpholino)propanesulfonic
acid (MOPS) pH 7.0 at 25 C. a
Progress curves for apoferritin
in the absence of Zn(II) (a),
apoferritin incubated with eight
Zn(II) per ferritin (b), and
apoferritin incubated with 24
Zn(II) per ferritin (c). Progress
curves were measured at
315 nm. b The speciﬁc activity
of the ﬁrst oxidation phase
attributed to the ferroxidase
center (FC) formation versus the
Zn(II)-to-ferritin ratio. c The
speciﬁc activity of the slow
oxidation phase attributed to the
core formation versus the
Zn(II)-to-ferritin ratio. The
speciﬁc activity was calculated
using an extinction coefﬁcient
of 2.5 cm
-1 mM
-1 [21]
J Biol Inorg Chem (2010) 15:1243–1253 1247
123Fluorescence spectroscopy was used to gain more
insight into the binding of Zn(II) to apoferritin and 48
Fe(II) per protein aerobically preloaded sample. Excitation
at 295 nm was used, which is speciﬁc for tryptophan [43].
Two tryptophans are located in the vicinity of the FC:
Trp122, which is approximately 10 A ˚ away from site A,
and Trp42, which is approximately 10 A ˚ away from site B
(Fig. 6a). Both tryptophans are located on the surface of
each subunit that faces the cavity of the protein. Addition
of Zn(II) increases the ﬂuorescence emission at 324 nm
presumably because of conformational changes in the
protein [42]. Figure 6b shows that binding of the ﬁrst 24
Zn(II) per protein clearly differs from that of subsequently
added Zn(II). Further additions of Zn(II) increase and shift
the ﬂuorescence emission spectra until saturation at
approximately 200 Zn(II) per protein.
Analysis of the ﬂuorescence emission spectrum of the 48-
Fe(II)-preloadedferritinshowedadifferentbindingpatternof
Zn(II) compared with that of apoferritin (Fig. 6c). It can be
seenthattheslopeofthecurveofZn(II)titrationtoapoferritin
at approximately 50 Zn(II) per protein (Fig. 6b) is similar to
theinitialslopeofthecurveofZn(II)titrationtothe48Fe(II)
Fig. 3 Binding of zinc to PfFtn. Isothermal titration calorimetry of
apoferritin with Zn(II). The concentration of apoferritin in the cell was
4.5 lM (24-mer); the concentration of Zn(II) was 6.5 mM in the
syringe. Measurements were done in 100 mM MOPS pH 7.0 and at
25 C.TheDHdatawereﬁttedtoamodelwithtwosetsofbindingsites.
The experimental parameters were as follows: total number of
injections60,volumeofeachinjection3 ll,duration6 s,spacing200 s
Table 1 Theromodynamic parameters for titration of apoferritin and
48 Fe(II) per protein aerobically preloaded Pyrococcus furiosus fer-
ritin (PfFtn)
Binding parameters Apo-PfFtn 48 Fe(II)/protein
preloaded PfFtn
N1 per subunit 1.8 ± 0.1 \0.1
K1 (M
-1) (2.4 ± 0.1) 9 10
4 (3.1 ± 1.0) 9 10
4
DH1 (kcal mol
-1) -3.8 ± 0.4 ND
DS1 (cal mol
-1 C
-1) 7.2 ± 1.4 ND
DG1 (kcal mol
-1) -6.0 ± 1.5 ND
N2 per subunit 1.3 ± 0.2 1.6 ± 0.4
K2 (M
-1) (6.2 ± 0.3) 9 10
3 (3.3 ± 0.5) 9 10
3
DH2 (kcal mol
-1)2 7 ± 4.0 19 ± 2.0
DS2 (cal mol
-1 C
-1) 105 ± 10 82 ± 3.0
DG2 (kcal mol
-1) -4.3 ± 1.0 -4.1 ± 1.0
The preloaded sample was incubated at room temperature for at least
3 h and then for 2 days at 4 C before titration. The concentration of
protein (24-mer) was 4.5 lM. The concentration of Zn(II) in the
syringe was 6.53 mM. The volume of each injection was 3 ll. The
temperature was 25 C
ND not determined
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Fig. 4 Inhibitory effect of zinc on iron binding by PfFtn. Progress
curves are shown for aerobic addition of 48 Fe(II) per ferritin to a 48-
iron-preloaded sample in the absence of Zn(II) (red), a preloaded
sample that was incubated with 24 Zn(II) per ferritin after preloading
(black), and a preloaded sample that was incubated with 24 Zn(II) per
ferritin prior to preloading (blue). The concentration of protein was
0.6 lM and 48 irons per ferritin were added aerobically to preload the
apoferritin. The buffer was 100 mM MOPS pH 7.0 and measurements
were done at 25 C
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123per protein preloaded sample (Fig. 6c). Therefore, it appears
that the ﬁrst saturation phase, corresponding to 24 Zn(II) per
protein, and part of the second phase, corresponding to 24
Zn(II) per protein, that are observed in binding of Zn(II) to
apoferritin have disappeared when apoferritin is preloaded
with 48 Fe(II) per protein.
Effect of phosphate on iron oxidation and core
formation of PfFtn
Iron was added aerobically to apo-PfFtn in three consec-
utive steps of 48 Fe(II) per ferritin, in the absence and
presence of a ratio of 500 phosphate to ferritin.
From Fig. 7a it can be seen that phosphate does not
affect the oxidation rate of the ﬁrst 48 Fe(II) per ferritin
aerobically added to apoferritin; however, it does increase
the iron-oxidation rate of subsequent additions of 48 Fe(II)
per ferritin by a factor of 6 ± 0.5 (based on measurements
with three different batches of protein). The effect of
Fig. 5 Effect of iron preloading on the binding of zinc to PfFtn.
Isothermal titration calorimetry of a 48 Fe(II) per ferritin preloaded
sample with Zn(II). The concentration of ferritin in the cell was
4.5 lM; the concentration of Zn(II) in the syringe was 6.5 mM. The
buffer was 100 mM MOPS pH 7.0 and measurements were done at
25 C. The experimental parameters were as follows: total number of
injections 60, volume of each injection 3 ll, duration 6 s, spacing
250 s
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Fig. 6 a Structure of the PfFtn subunit with the FC in the middle and
two tryptophans, Trp42 and Trp122, each approximately 10 nm away
from the FC (PDB 2JD7). b Absolute increase (corrected with the
spectrum of apoferritin) in ﬂuorescence emission of apoferritin
titrated with Zn(II) at 324 nm. The concentration of protein was
0.7 lM. The buffer was MOPS 50 mM pH 7.0. The concentration of
aqueous ZnSO4 solution was 4.2 mM. c Absolute increase (corrected
with the spectrum of the preloaded sample) in ﬂuorescence emission
of 48 Fe(II) per protein preloaded ferritin titrated with Zn(II) at
324 nm. The concentration of protein was 0.7 lM and measurements
were done in 50 mM MOPS pH 7.0. The concentration of aqueous
ZnSO4 solution was 4.2 mM
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123phosphate on the ﬁrst 48 Fe(II) per protein added to apo-
ferritin was also measured by rapid stopped ﬂow: the data in
Fig. 7b conﬁrm the results of the progress curve measure-
ments and show that phosphate does not accelerate the fast
oxidation of the ﬁrst 48 Fe(II) per protein added to apo-
ferritin. It has been shown that not only phosphate but also
other oxoanions such as vanadate increase the oxidationrate
of iron [38]. Therefore, the effect of vanadate on the iron-
oxidation rate of PfFtn was also measured. Fe(II) was again
added in three steps of 48 Fe(II) per ferritin, in the presence
of a vanadate-to-ferritin ratio of 100. From Fig. 7c it can be
seen that the maximum absorbance due to the ﬁrst addition
does not change, whereas vanadate increases the maximum
absorbance of the second and the third steps. The effect of
phosphate on the initial rates of Fe(II) oxidation was also
checked by measuring oxygen uptake rates (data not
shown): phosphate does not affect the initial oxygen uptake
rate of the ﬁrst 48 Fe(II) per ferritin added to apoferritin, but
it increases the oxidation rate of subsequent additions of the
same amount of Fe(II) to PfFtn.
As shown in Fig. 2, when apoferritin is incubated with
24 Zn(II) per ferritin and then 48 Fe(II) per ferritin are
added, the oxidation process shows two phases, a fast and a
slow one. When this experiment is repeated in the presence
of 500 phosphates per ferritin, the oxidation rate of iron in
the ﬁrst process is not changed, but the oxidation rate of the
second phase is increased approximately twofold (Fig. 8a).
To test whether functioning of the FC is required for
phosphate to increase the oxidation rate of Fe(II), the effect
of phosphate was checked when either apoferritin or 48
Fe(II) per ferritin preloaded protein was incubated with 24
Zn(II) per monomer. Again two samples were prepared: (1)
apoferritin incubated with 24 Zn(II) per monomer for
10 min and then aerobically incubated with 48 Fe(II) per
monomer for approximately1 h, and (2) apoferritin loaded
with 48 Fe(II) per monomer and then incubated with 24
Zn(II) per monomer for 10 min. The control was apofer-
ritin incubated aerobically with 48 Fe(II) per ferritin in the
absence of any Zn(II). The progress curves were measured
for the samples and the control at 315 nm after addition of
48 Fe(II) per protein (Fig. 8b). The results show that the
Fig. 7 Stimulatory effect of phosphate and vanadate on the iron-
oxidation activity of PfFtn. a Three consecutive additions of 48 Fe(II)
per ferritin were made in the absence and presence of a phosphate-to-
ferritin ratio of 500 (1.65 lM ferritin). b Rapid stopped-ﬂow
measurements of the initial rate of oxidation of the ﬁrst 48 Fe(II)
per protein by apoferritin in the absence and presence of 500
phosphates per protein. The concentration of protein was 1 lM, and
buffer was 400 mM MOPS pH 7.0. Data were collected at 25 C. The
pH of the anaerobic ferrous sulfate solution was 2.5. c Three
consecutive additions of 48 Fe(II) per ferritin in the absence and
presence of 100 vanadates per ferritin (0.825 lM ferritin). Measure-
ments were done in 100 mM MOPS pH 7.0, and at 25 C
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123initial oxidation rate for sample 1 is lower than that for the
control and that for sample 2. The progress curves for the
latter two are identical within experimental error.
To check for phosphate binding to apoferritin or to the
Fe(III) in the FC, ITC was used. Titration of phosphate to
apoferritin and 48 Fe(II) per ferritin preloaded PfFtn did
not show any endothermic or exothermic phosphate bind-
ing (not shown).
Discussion
It has been reported that Zn(II) binds to the FC of certain
ferritins and inhibits efﬁcient iron oxidation [26–32]. We
used the inhibitory effect of Zn(II) to follow the functioning
oftheFCinironcore formationofPfFtn.Tothisgoal,ﬁrstly
the inhibiting action of Zn(II) on apo-PfFtn was studied.
Apoferritinsampleswere incubatedwithZn(II)inZn(II)-to-
ferritin ratios between 0 and 100. Then 48 Fe(II) per ferritin
were added aerobically. Two different processes were
observed.Theratesofbothprocessesdecreaseastheamount
ofZn(II)increases.Itisconcludedthat24Zn(II)perprotein,
i.e., one Zn(II) per subunit, is enough to impair the func-
tioningofthe FC asboth the rate of oxidation of Fe(II) in the
FC and the rate of core formation decrease. The effect of
Zn(II) on the overall core formation reaction suggests that
this formation depends on the presence of a stable FC. This
observation is in agreement with our previous observation
[22] that when an increasing amount of stable FC is formed
upon aerobic preloading of apoferritin with different Fe(II)-
to-ferritin ratios, the speciﬁc activity of the second reaction
increases for Fe(II)-to-ferritin preloading ratios of 1–48.
Addition of Zn(II) to apoferritin beyond 24 Zn(II) per sub-
unit further decreased the iron-oxidation rate, and at 100
Zn(II) per protein a very slow rate, i.e., 55-fold less than in
the absence of zinc, was observed. This slow oxidation of
Fe(II) perhaps occurs because of binding of iron to acidic
residues in the core and their oxidation by an unknown
process. This process may be similar to the slow oxidation
and mineralization of iron by the recombinant L ferritin that
lacks the FC residues [45]. ITC of apoferritin with Zn(II)
shows two independent binding sites, one with a stoichi-
ometry of approximately 2 and relatively higher afﬁnity,
consistentwithbindingoftwoZn(II)totheFC,andonewith
a stoichiometry of approximately 1.3 and lower afﬁnity.
Fitting the data with three sequential binding sites suggests
that the afﬁnity of binding to one of the FC sites is slightly
higher than that for the other site.
Fluorescence spectroscopy of Zn(II) titration of apofer-
ritin shows two phases. Binding of the ﬁrst 24 Zn(II) per
protein causes a minor increase and shift in the ﬂuores-
cence emission spectra of PfFtn. Since these changes in
tryptophan ﬂuorescence typically reﬂect conformational
changes in the protein [46], the data suggest that the ﬁrst 24
Zn(II) per protein induce only a minor conformational
change, possibly because of binding of Zn(II) to site A of
the FC with His53 as a ligand to the metal. The observation
of two phases for Zn(II) binding to apo-PfFtn differs from
A 
B 
0.09
0.06
0.03
0.00
A
b
s
o
r
b
a
n
c
e
 
(
3
1
5
 
n
m
)
600 400 200 0
Time (s)
a
b
a: No phosphate
b: 500 phosphate/ferritin
60x10
-3
40
20
0
A
b
s
o
r
b
a
n
c
e
 
(
3
1
5
 
n
m
)
400 300 200 100 0
Time (Sec)
 No Zn(II)
 Incubated with 24 Zn(II) prior to preloading
 Incubated with 24 Zn(II) after preloading
Fig. 8 Effect of zinc on the stimulation by phosphate of the iron-
oxidation activity of PfFtn. a Forty-eight Fe(II) were added aerobi-
cally in the presence or absence of phosphate to apoferritin samples
(0.6 lM) that had been preincubated with 24 Zn(II) per ferritin. b
Forty-eight Fe(II) per ferritin were added aerobically to a PfFtn
sample in which the FCs were ﬁlled by preloading apoferritin with 48
irons per 24-mer in the absence of Zn(II) (red), a PfFtn sample that
was aerobically incubated with 48 Fe(II) and subsequently with 24
Zn(II) per ferritin (black), and a PfFtn sample that was incubated with
24 Zn(II) and then with 48 Fe per 24-mer (blue). The buffer was
100 mM MOPS pH 7.0 and measurements were done at 25 C
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123the results reported for BFR [43]. A possible reason could
be the difference in the amino acid residues of the FC
between PfFtn and BFR (Fig. 9). Both sites of the FC in
BFR have a histidine, His54 and His130, as a ligand.
His130 in BFR is replaced by a glutamate, Glu130, in
PfFtn. In BFR two glutamates act as bridging ligands
between sites A and B, Glu51 and Glu127. In PfFtn only
one glutamate, Glu50, acts as the bridging ligand. The
second bridging ligand in BFR, Glu127, is replaced with a
glutamine, Gln127, in PfFtn. Finally, in PfFtn two trypto-
phans, Trp122 and Trp42, are located in the vicinity of the
PfFtn FC compared with one tryptophan, Trp133, in BFR.
The ﬁndings that Zn(II) initially ﬁlls the FC and has higher
afﬁnity for one of the FC sites are similar to results pre-
viously reported for E. coli ferritin A (EcFtnA) [47]. It has
been shown that in EcFtnA, Zn(II) initially ﬁlls the FC and
it has higher afﬁnity for site A of the FC. Alignment of the
amino acid sequences of several ferritins (Fig. 9) shows
that PfFtn and EcFtnA have a high degree of identity and
the residues of the FC are conserved between them. In
comparison, a different Zn(II) binding pattern has been
observed for HuHF [29]. On the basis of ITC and the
kinetics of iron-oxidation experiments, it has been sug-
gested that in HuHF one Zn(II) binds to the threefold
channel, and then other low-afﬁnity sites, including the FC,
are ﬁlled. Differences between the amino acid residues of
the FC and the threefold channel of HuHF versus PfFtn
could be the basis for the observed differences in the Zn(II)
binding patterns in these two ferritins. The alignment of the
two ferritins (Fig. 9) shows that in HuHF there is a cysteine
in the threefold channel, which is replaced by Arg117 in
PfFtn. Besides, in PfFtn, site B of the FC has a glutamate,
Glu130, which is absent in HuHF.
The kinetic measurements in the presence of Zn(II) with
apoferritin and preloaded ferritin showed that Zn(II) has an
inhibitory effect only when apoferritin is incubated with
Zn(II) before preloading with iron. ITC and ﬂuorescence
spectroscopy experiments indicated that preloading apo-
ferritin with 48 Fe(II) per ferritin ﬁlls the Zn(II) primary
binding sites. Because it is known that Fe(II) is primarily
oxidized in the FC, the kinetics, ﬂuorescence emission
spectra, and ITC results together suggest that Zn(II) pri-
marily binds to the FC. Two conclusions are drawn: (1) the
functional model in which Fe(III) is stable in the FC is
corroborated because in the alternative ‘‘substrate model’’
zinc would be able to bind following transfer of Fe–O–Fe
units from the FC to the core; and (2) formation of a
functional FC is essential for further catalytic oxidation of
Fe(II), by PfFtn. Alternatively, it may be surmised that
Zn(II) binds to other places in the core and then prevents
core formation or it may bind to a site in threefold channels
and prevent access of Fe(II) to the FC as a substrate site. In
both of these alternative scenarios it is expected that Zn(II)
binding to apoferritin and to 48 Fe(II) per protein preloaded
sample when measured by ITC and ﬂuorescence emission
would show similar patterns, which is, however, con-
tradicted by our results.
The role, if any, of phosphate in initial iron minerali-
zation by ferritin is not known. It has been proposed that
phosphate binds to the core [33–35] and stimulates the core
surface redox reaction [36]. We checked the effect of
phosphate and vanadate as an analog of phosphate on the
core formation reaction. The results suggest that phosphate
and vanadate do not affect the fast oxidation of the ﬁrst 48
Fe(II) per ferritin added to apoferritin, and are therefore not
involved in formation of the FC. Phosphate and vanadate
Fig. 9 Amino acid sequence alignment of human H-chain ferritin,
bullfrog M-chain ferritin, E. coli ferritin A, E. coli bacterioferritin,
and PfFtn. The residues of site A that are conserved in all ferritins are
shown in pink and those of site B are shown in orange. The residues
that are bridging ligands between sites A and B are shown in green
and the residue of site B that varies among ferritins is shown in blue.
A conserved tyrosine residue in the vicinity of site B of the FC is
shown in yellow. The sequence of ferritins was aligned using the T-
Coffee tool on the EMBL-EBI server
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123increase the oxidation rate of Fe(II) only after formation of
the FC. The increase in the Fe(II) oxidation rate after FC
formation is not signiﬁcantly different in the presence of
phosphate versus vanadate, indicating that the effect is not
speciﬁc for phosphate. However, the ﬁnal absorption at
315 nm from the core is approximately twofold higher in
the presence of vanadate compared with phosphate, which
strongly suggests that the oxoanions actually become part
of the core structure only after FC formation.
Finally, it is observed that if the functioning of the FC is
impaired by incubating apoferritin with Zn(II), phosphate
can no longer increase the oxidation rate. Therefore,
although studies by other groups have suggested that
phosphate binds to the core and increases the initial iron
oxidation [37], our results rather suggest that preformation
of the FC and not the core is necessary for phosphate to
increase the initial iron-oxidation rate by PfFtn. Further-
more, the phosphate and vanadate experiments once more
suggest that oxidation of the ﬁrst 48 Fe(II) per ferritin
proceeds via a mechanism different from that for any sub-
sequent addition of Fe(II). To understand the mechanism(s)
by which phosphate increases the oxidation rate of Fe(II)
after FC formation, further investigations are required.
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